(2'R,4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2'-Butyl-2'-methoxy-4a,6a,8-trimethyl-5a,6,6a,8,9,9a,9b,10-octahydro-11H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH)-dione

CAT:
572-TRC-B580705-100MG
Size:
100 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(2'R,4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2'-Butyl-2'-methoxy-4a,6a,8-trimethyl-5a,6,6a,8,9,9a,9b,10-octahydro-11H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH)-dione - image 1

(2'R,4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2'-Butyl-2'-methoxy-4a,6a,8-trimethyl-5a,6,6a,8,9,9a,9b,10-octahydro-11H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH)-dione

  • Hazard Statement:

    No Data Available
  • Smiles:

    O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@@]24[C@H](C[C@@]5(C)[C@]3(C[C@H](C)[C@]5(O[C@](CCCC)(OC)OC6)C6=O)[H])O4)=C1
  • Molecular Formula:

    C27H36O6
  • Molecular Weight:

    470.61
  • InChI:

    InChI=1S/C28H38O6/c1-6-7-11-26(31-5)32-16-22(30)27(34-26)17(2)13-21-20-9-8-18-14-19(29)10-12-24(18,3)28(20)23(33-28)15-25(21,27)4/h10,12,14,17,20-21,23H,6-9,11,13,15-16H2,1-5H3/t17-,20-,21-,23-,24-,25-,26+,27-,28+/m0/s1
  • Additionnal Information:

    IUPAC name: (2'R,4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2'-butyl-2'-methoxy-4a,6a,8-trimethyl-5a,6,6a,8,9,9a,9b,10-octahydro-11H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH)-dione
  • Shipping Conditions:

    Room Temperature

Related Products

CAT

Name

TRC-B580705-100MG(2'R,4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2'-Butyl-2'-methoxy-4a,6a,8-trimethyl-5a,6,6a,8,9,9a,9b,10-octahydro-11H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH)-dione
TRC-D443658-1G(4aS,4bS,4'R,5aS,6aS,8S,9aS,9bS)-2',2'-Diethyl-4a,6a,8-trimethyl-6,6a,8,9,9a,9b,10,11-octahydro-2H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH,5aH)-dione
TRC-D443658-500MG(4aS,4bS,4'R,5aS,6aS,8S,9aS,9bS)-2',2'-Diethyl-4a,6a,8-trimethyl-6,6a,8,9,9a,9b,10,11-octahydro-2H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH,5aH)-dione
TRC-D443658-2.5G(4aS,4bS,4'R,5aS,6aS,8S,9aS,9bS)-2',2'-Diethyl-4a,6a,8-trimethyl-6,6a,8,9,9a,9b,10,11-octahydro-2H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,4'-[1,3]dioxane]-2,5'(4aH,5aH)-dione
TRC-H941315-25MG(4aS,4bS,5aS,7R,8R,9aR,9bS)-7-hydroxy-7-(2-hydroxyacetyl)-1,4a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one
TRC-H941310-25MG(4aS,4bS,5aS,7R,8R,9aR,9bS,11R)-7-Hydroxy-7-(2-hydroxyacetyl)-4a,8,11-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one
TRC-O236140-100MG1,2,3,4,4a,9,10,10a-Octahydro-3,7,8-trimethyl-phenanthrene
TRC-C176953-1MG(4R,4aS,6S,6aR,11bS)-6-Carboxy-3-(cyclopropylmethyl)-1,2,3,4,4a,5,6,6a-octahydro-4a,6,8-trihydroxy-3
TRC-D121250-25MGN-[(6aS,8S)-2-(2,4-Difluorophenyl)-5,6,6a,7,8,9,10,12-octahydro-6,12-dioxopyrido[2,1-c][1,4]benzodiazepin-8-yl]-N'-(1-methylethyl)-urea
C176950(4R,4aS,6S,6aR,11bS)-6-Carboxy-3-(cyclopropylmethyl)-1,2,3,4,4a,5,6,6a-octahydro-4a,6,8-trihydroxy-3-methyl-4,11-methanobenzofuro[3',2':2,3]cyclopenta[1,2-c]pyridinium Bromide